A carregar...
Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) is considered to be a hepatic manifestation of metabolic syndrome, and its incidence is rapidly increasing worldwide. It is currently the most common chronic liver disease. NASH can progress to liver cirrhosis and hepatocel...
Na minha lista:
| Publicado no: | World J Gastroenterol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4385525/ https://ncbi.nlm.nih.gov/pubmed/25852263 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i13.3777 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|